- Cost Avoidance and Clinical Pharmacist Interventions on Hospitalized Patients in Hematologic malignancies
-
Kim YS, Hong SY, Kim YH, Choi KS, Lee JH, Lee JY, Lee E
- KMID: 2533901
- Korean J Clin Pharm.
- 2022 Sep;32(3):215-225.
- doi: 10.24304/kjcp.2022.32.3.215
Background: Patients with hematologic cancers have a risk of drug-related problems (DRPs) from medications associated with chemotherapy and supportive care. Although the role of oncology pharmacists has been widely documented... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of Clinical Outcomes by Therapeutic Dosing Interval of Denosumab (Prolia ® ) and Calcium-Vitamin D Prescriptions
-
Kim Y, Kim J, Doh H, Jeong YM, Lee J, Lee JY, Lee E
- KMID: 2533898
- Korean J Clin Pharm.
- 2022 Sep;32(3):185-190.
- doi: 10.24304/kjcp.2022.32.3.185
Background: Denosumab (Prolia®) is administered every 6 months for osteoporosis treatment. Co-administration of calcium and vitamin D is required to minimize hypocalcemia risk. We evaluated clinical outcomes based on the... -
- CITED
-
- Close
- SHARE
-
- Close
- Assessing the Effectiveness and Safety of Direct-acting Antiviral Treatment in Korean Patients with Hepatitis C Virus Genotype 1b or 2 at a Tertiary Care Hospital
-
Park MS, Yang YM, Park KH, Yoon H, Kim JS, Choi EJ
- KMID: 2533899
- Korean J Clin Pharm.
- 2022 Sep;32(3):191-203.
- doi: 10.24304/kjcp.2022.32.3.191
Background: Direct-acting antivirals are recommended for the treatment of chronic hepatitis C virus in Korea. However, evaluation of direct-acting antiviral regimens in a real-world setting is limited. The aims of... -
- CITED
-
- Close
- SHARE
-
- Close
- Identifying the Patterns of Adverse Drug Responses of Cetuximab
-
Park JH
- KMID: 2533902
- Korean J Clin Pharm.
- 2022 Sep;32(3):226-237.
- doi: 10.24304/kjcp.2022.32.3.226
Background: Monoclonal antibodies for the treatment of patients with different types of cancer, such as cetuximab, have been widely used for the past 10 years in oncology. Although drug information... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Regulation on Recruitment Advertising for Clinical Trial Subjects in Korea
-
Kim HJ, Sohn HS
- KMID: 2533896
- Korean J Clin Pharm.
- 2022 Sep;32(3):166-177.
- doi: 10.24304/kjcp.2022.32.3.166
Background: Recently clinical trials have expanded extensively in Korea; thus, ensuring the rights of subjects participating in clinical trials is imperative. Accordingly, national regulations on subject recruitment advertisement were enforced... -
- CITED
-
- Close
- SHARE
-
- Close
- Medication Prescribing Status in Pediatric Patients with Migraine
-
Rhew K
- KMID: 2533897
- Korean J Clin Pharm.
- 2022 Sep;32(3):178-184.
- doi: 10.24304/kjcp.2022.32.3.178
Background: Migraine is one of the leading causes of poor quality of life and disability, and migraine incidences in pediatrics are increasing. Proper medication is important for the preventive and... -
- CITED
-
- Close
- SHARE
-
- Close
- Development of Eligibility Criteria for Comprehensive Medication Management Programs in Long-term Care Facilities Using RAND/UCLA Appropriateness Method
-
Jang S, Kang C, Ah Y, Lee JY, Kim JH, Jang S
- KMID: 2533905
- Korean J Clin Pharm.
- 2022 Sep;32(3):260-269.
- doi: 10.24304/kjcp.2022.32.3.260
Background: Comprehensive medication management is essential to achieve safe and optimal drug use for the elderly in long-term care facilities (LTCF). This study aimed to develop eligibility criteria for ”Comprehensive... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of ABCB1 C3435T Polymorphism on Treatment Response of Vitamin K Antagonists: A Systematic Review and Meta-analysis
-
Lee SY, An SH
- KMID: 2533903
- Korean J Clin Pharm.
- 2022 Sep;32(3):238-250.
- doi: 10.24304/kjcp.2022.32.3.238
Objective: The aim of this study was to examine the impact of ATP-binding cassette subfamily B member 1 (ABCB1) C3435T polymorphism on the treatment response of patients to vitamin K... -
- CITED
-
- Close
- SHARE
-
- Close
- Real-world Adverse Events Associated with Fluconazole and Itraconazole: Analysis of Nationwide Data Using a Spontaneous Reporting System Database
-
Lee Yg, Lee J, Chun P
- KMID: 2533900
- Korean J Clin Pharm.
- 2022 Sep;32(3):204-214.
- doi: 10.24304/kjcp.2022.32.3.204
Objective: This study aimed to investigate the occurrence and types of the adverse events (AEs) associated with oral fluconazole and itraconazole and factors associated with specific types of AEs. Methods:... -
- CITED
-
- Close
- SHARE
-
- Close
- Analysis of Treatment Pattern in COPD Patients Using Health Insurance Claims Data: Focusing on Inhaled Medications
-
Lim H, Park M
- KMID: 2533895
- Korean J Clin Pharm.
- 2022 Sep;32(3):155-165.
- doi: 10.24304/kjcp.2022.32.3.155
Background: Chronic obstructive pulmonary disease (COPD) is not completely reversible and requires long-term management with appropriate treatment. This study aimed to analyze trends in treatment regimens and medication costs for... -
- CITED
-
- Close
- SHARE
-
- Close
- Resuscitation Fluids for Patients at High Risk of Multiple Organ Dysfunction Syndromes: A Systematic Review and Meta-analysis
-
Nam JH, Kwack HJ, Ha WS, Chung JE
- KMID: 2533904
- Korean J Clin Pharm.
- 2022 Sep;32(3):251-259.
- doi: 10.24304/kjcp.2022.32.3.251
Background: Intravenous fluid therapy is one of the most common interventions in critically ill patients. Normal saline is frequently used, but there have been some concerns about hyperchloremia. Due to... -
- CITED
-
- Close
- SHARE
-
- Close
